Ftse Mib
34.375,92
0,00%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.873,47
-1,51%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adicet Bio Inc (ACET) Adicet Bio Inc (ACET) Notizie

ACET

Adicet Bio (ACET)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET
DataOraFonteTitoloSimboloCompagnia
30/11/202222:00Business WireAdicet Bio to Present at the Virtual JMP Securities Hematology and Oncology SummitNASDAQ:ACETAdicet Bio Inc
29/11/202213:00Business WireAdicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory OfficerNASDAQ:ACETAdicet Bio Inc
15/11/202222:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACETAdicet Bio Inc
14/11/202204:56TipRanksBTIG Remains a Buy on Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
10/11/202223:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACETAdicet Bio Inc
10/11/202220:35TipRanksAdicet Bio (ACET) Receives a Buy from JonesTradingNASDAQ:ACETAdicet Bio Inc
08/11/202222:10Business WireAdicet Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
07/11/202214:00Business WireAdicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:ACETAdicet Bio Inc
04/11/202206:36TipRanksBTIG Keeps Their Buy Rating on Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
03/11/202217:25TipRanksH.C. Wainwright Remains a Buy on Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
03/11/202214:00Business WireAdicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)NASDAQ:ACETAdicet Bio Inc
01/11/202212:00Business WireAdicet Bio to Present at the 2022 Jefferies London Healthcare ConferenceNASDAQ:ACETAdicet Bio Inc
31/10/202223:58Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
05/10/202214:00Business WireAdicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:ACETAdicet Bio Inc
07/09/202222:10Business WireAdicet Bio to Present at Upcoming Investor ConferencesNASDAQ:ACETAdicet Bio Inc
11/08/202223:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACETAdicet Bio Inc
10/08/202213:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACETAdicet Bio Inc
10/08/202213:00Business WireAdicet Reports Second Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
11/06/202211:07TipRanksAdicet Bio (ACET) Receives a Buy from BTIGNASDAQ:ACETAdicet Bio Inc
10/06/202206:15TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Guardant Health (GH)NASDAQ:ACETAdicet Bio Inc
07/06/202206:15TipRanksAdicet Bio (ACET) Gets a Buy Rating from JMP SecuritiesNASDAQ:ACETAdicet Bio Inc
06/06/202213:00Business WireAdicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual MeetingNASDAQ:ACETAdicet Bio Inc
27/05/202214:12TipRanksAdicet Bio (ACET) Received its Third Buy in a RowNASDAQ:ACETAdicet Bio Inc
27/05/202212:16TipRanksH.C. Wainwright Sticks to Their Buy Rating for Adicet Bio (ACET)NASDAQ:ACETAdicet Bio Inc
26/05/202223:00Business WireAdicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL)NASDAQ:ACETAdicet Bio Inc
13/05/202212:16TipRanksAdicet Bio (ACET) Gets a Buy Rating from H.C. WainwrightNASDAQ:ACETAdicet Bio Inc
12/05/202222:10Business WireAdicet Reports First Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
10/05/202212:11Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACETAdicet Bio Inc
05/05/202213:00Business WireAdicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell MalignanciesNASDAQ:ACETAdicet Bio Inc
27/04/202216:00Business WireAdicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:ACETAdicet Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network